Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant Treatment for Patients with Resectable HER2-Positive Gastric Cancer-Reference-Cited by-同舟云学术

Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant Treatment for Patients with Resectable HER2-Positive Gastric Cancer

Published:2021-01-03 Issue:8 Volume:28 Page:4413-4422
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

He Qifei,Chen Jiahui,Zhou Kai,Jin Chenggen,Wang Anqiang,Ji Ke,Ji Xin,Zhang Ji,Wu Xiaojiang,Li Xia,Bu Zhaode,Ji Jiafu^ORCID

Funder

China Postdoctoral Science Foundation

San Ming Project of Shenzhen city

Peking University Clinical Scientist Program

National Science Foundation for Young Scientists of China

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-020-09405-6.pdf

Reference37 articles.

1. Freddie B, Jacques F, Isabelle S, Rebecca LS, Lindsey AT, Ahmedin J. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;6:394–424.

2. Lei Y, Rongshou Z, Ning W, et al. Incidence and mortality of stomach cancer in China, 2014. Chin J Cancer Res. 2018;3:291–8.

3. Hiroyuki A, Takako EN. Recent developments of systemic chemotherapy for gastric cancer. Cancers. 2020;5:10–3390.

4. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric cancer. Epub 14 Feb 2020. https://doi.org/10.1007/s10120-020-01042-y.

5. National Health Commission of the People’s Republic of China. Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version). Chin J Cancer Res. 2019;5:707–37.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trastuzumab-induced optic neuritis: “blindness” side effect;Journal of Oncology Pharmacy Practice;2024-08-14

2. Safety and Efficacy of Neoadjuvant Chemoimmunotherapy in Gastric Cancer Patients with a PD-L1 Positive Status: A Case Report;Current Issues in Molecular Biology;2023-09-19

3. HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives;Biomarker Research;2022-09-30

4. Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer;Cancers;2022-09-25

5. Assessment of the short-term outcomes of laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: A prospective single-armed clinical trial;Surgery;2022-07